Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
Docsorwbicin
 | |
| Enghraifft o: | math o endid cemegol  |
|---|---|
| Math | anthracycline polyketide, anthracycline antibiotic |
| Màs | 543.174 uned Dalton |
| Fformiwla gemegol | C₂₇h₂₉no₁₁ |
| Enw WHO | Doxorubicin |
| Clefydau i'w trin | Canser y fron, canser ofaraidd, canser y bledren, neuroblastoma, susceptibility to, hepatoblastoma, transitional cell carcinoma, plasmablastic lymphoma, mature t-cell and nk-cell lymphoma, mantle cell lymphoma, t-cell lymphoma, precursor t-cell lymphoblastic leukemia, lewcemia lymffosytig cronig, liwcemia myeloid aciwt, invasive ductal carcinoma, precursor t-cell acute lymphoblastic leukemia, lymffoma ddi-hodgkin, primary mediastinal b-cell lymphoma, bone sarcoma, post-transplant lymphoproliferative disorder, lymffoma, hematologic cancer, b-cell lymphoma, diffuse large b-cell lymphoma |
| Beichiogrwydd | Categori beichiogrwydd awstralia d, categori beichiogrwydd unol daleithiau america d |
| Rhan o | doxorubicin metabolic process, response to doxorubicin, doxorubicin transport, ABC-type doxorubicin transporter activity |
 Ffeiliau perthnasol ar Gomin Wicimedia | |
Mae docsorwbicin, sy’n cael ei werthu dan yr enw masnachol Adriamycin ymysg eraill, yn feddyginiaeth cemotherapi a ddefnyddir i drin canser.[1] Y fformiwla cemegol ar gyfer y cyffur hwn yw C₂₇H₂₉NO₁₁. Mae docsorwbicin yn gynhwysyn actif yn Adriamycin.
- ↑ Pubchem. "Docsorwbicin". pubchem.ncbi.nlm.nih.gov (yn Saesneg). Cyrchwyd 2018-02-28.
Previous Page Next Page
